Industry Growth Insights published a new data on “TIL Therapy Market”. The research report is titled “TIL Therapy Market research by Types (Single Injection, Multiple Injections), By Applications (Stomach Cancer, Cancer of Pancreas, Hepatoma, Uterine/Endometrial Carcinoma, Cervical Carcinoma, Urethral Carcinoma, Renal-cell Carcinoma, Other), By Players/Companies Lovance, MacroGenics, TILT Biotherapeutics, Genocea, Orgenesis, Cellectis, Lonza, Lytix Biopharma, PolyBioCept AB”.
Scope Of The Report
Report Attributes
Report Details
Report Title
TIL Therapy Market Research Report
By Type
Single Injection, Multiple Injections
By Application
Stomach Cancer, Cancer of Pancreas, Hepatoma, Uterine/Endometrial Carcinoma, Cervical Carcinoma, Urethral Carcinoma, Renal-cell Carcinoma, Other
By Companies
Lovance, MacroGenics, TILT Biotherapeutics, Genocea, Orgenesis, Cellectis, Lonza, Lytix Biopharma, PolyBioCept AB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global TIL Therapy Market Report Segments:
The global TIL Therapy market is segmented on the basis of:
Types
Single Injection, Multiple Injections
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Stomach Cancer, Cancer of Pancreas, Hepatoma, Uterine/Endometrial Carcinoma, Cervical Carcinoma, Urethral Carcinoma, Renal-cell Carcinoma, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lovance
- MacroGenics
- TILT Biotherapeutics
- Genocea
- Orgenesis
- Cellectis
- Lonza
- Lytix Biopharma
- PolyBioCept AB
Highlights of The TIL Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Injection
- Multiple Injections
- By Application:
- Stomach Cancer
- Cancer of Pancreas
- Hepatoma
- Uterine/Endometrial Carcinoma
- Cervical Carcinoma
- Urethral Carcinoma
- Renal-cell Carcinoma
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the TIL Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
TIL therapy is a form of cognitive behavioral therapy that uses technology to help people change their thoughts and behaviors. The therapist provides feedback through a computer or phone, and the person using TIL therapy can track their progress over time.
Some of the key players operating in the til therapy market are Lovance, MacroGenics, TILT Biotherapeutics, Genocea, Orgenesis, Cellectis, Lonza, Lytix Biopharma, PolyBioCept AB.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 TIL Therapy Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 TIL Therapy Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 TIL Therapy Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the TIL Therapy Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global TIL Therapy Market Size & Forecast, 2018-2028 4.5.1 TIL Therapy Market Size and Y-o-Y Growth 4.5.2 TIL Therapy Market Absolute $ Opportunity
Chapter 5 Global TIL Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 TIL Therapy Market Size Forecast by Type
5.2.1 Single Injection
5.2.2 Multiple Injections
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global TIL Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 TIL Therapy Market Size Forecast by Applications
6.2.1 Stomach Cancer
6.2.2 Cancer of Pancreas
6.2.3 Hepatoma
6.2.4 Uterine/Endometrial Carcinoma
6.2.5 Cervical Carcinoma
6.2.6 Urethral Carcinoma
6.2.7 Renal-cell Carcinoma
6.2.8 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global TIL Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 TIL Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America TIL Therapy Analysis and Forecast
9.1 Introduction
9.2 North America TIL Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America TIL Therapy Market Size Forecast by Type
9.6.1 Single Injection
9.6.2 Multiple Injections
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America TIL Therapy Market Size Forecast by Applications
9.10.1 Stomach Cancer
9.10.2 Cancer of Pancreas
9.10.3 Hepatoma
9.10.4 Uterine/Endometrial Carcinoma
9.10.5 Cervical Carcinoma
9.10.6 Urethral Carcinoma
9.10.7 Renal-cell Carcinoma
9.10.8 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe TIL Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe TIL Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe TIL Therapy Market Size Forecast by Type
10.6.1 Single Injection
10.6.2 Multiple Injections
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe TIL Therapy Market Size Forecast by Applications
10.10.1 Stomach Cancer
10.10.2 Cancer of Pancreas
10.10.3 Hepatoma
10.10.4 Uterine/Endometrial Carcinoma
10.10.5 Cervical Carcinoma
10.10.6 Urethral Carcinoma
10.10.7 Renal-cell Carcinoma
10.10.8 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific TIL Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific TIL Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific TIL Therapy Market Size Forecast by Type
11.6.1 Single Injection
11.6.2 Multiple Injections
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific TIL Therapy Market Size Forecast by Applications
11.10.1 Stomach Cancer
11.10.2 Cancer of Pancreas
11.10.3 Hepatoma
11.10.4 Uterine/Endometrial Carcinoma
11.10.5 Cervical Carcinoma
11.10.6 Urethral Carcinoma
11.10.7 Renal-cell Carcinoma
11.10.8 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America TIL Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America TIL Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America TIL Therapy Market Size Forecast by Type
12.6.1 Single Injection
12.6.2 Multiple Injections
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America TIL Therapy Market Size Forecast by Applications
12.10.1 Stomach Cancer
12.10.2 Cancer of Pancreas
12.10.3 Hepatoma
12.10.4 Uterine/Endometrial Carcinoma
12.10.5 Cervical Carcinoma
12.10.6 Urethral Carcinoma
12.10.7 Renal-cell Carcinoma
12.10.8 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) TIL Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) TIL Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) TIL Therapy Market Size Forecast by Type
13.6.1 Single Injection
13.6.2 Multiple Injections
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) TIL Therapy Market Size Forecast by Applications
13.10.1 Stomach Cancer
13.10.2 Cancer of Pancreas
13.10.3 Hepatoma
13.10.4 Uterine/Endometrial Carcinoma
13.10.5 Cervical Carcinoma
13.10.6 Urethral Carcinoma
13.10.7 Renal-cell Carcinoma
13.10.8 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 TIL Therapy Market: Competitive Dashboard
14.2 Global TIL Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lovance
14.3.2 MacroGenics
14.3.3 TILT Biotherapeutics
14.3.4 Genocea
14.3.5 Orgenesis
14.3.6 Cellectis
14.3.7 Lonza
14.3.8 Lytix Biopharma
14.3.9 PolyBioCept AB